Please login to the form below

Not currently logged in
Email:
Password:

Suzanne Gagnon joins Idis as CMO

She was formerly chief medical officer at Icon

Idis Suzanne GagnonIdis has appointed Dr Suzanne Gagnon as its first chief medical officer.

Dr Gagnon will lead global medical affairs at Idis, which specialises in partnering with pharma firms to support patient access to medicines.

She was most recently chief medical officer at neuroscience company NuPathe, prior to which she spent ten years as chief medical officer at the clinical research organisation (CRO) Icon,

During her time at Icon, she gained senior level experience in medical, regulatory and clinical research operations, overseeing a staff of 400 professionals across 10 global locations.

"Suzanne brings senior leadership to our team and a unique blend of industry expertise to our customers that will help guide development and implementation of programmes that balance stakeholder requirements and effectively address the needs of patients," said Natalie Douglas, CEO of Idis. 

In addition to her industry experience, Dr Gagnon is adjunct professor, pharmaceutical product development at West Chester University, Pennsylvania.

13th March 2013

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Research Partnership

We are the largest independent healthcare market research and consulting agencies in the world. Trusted partner to the global pharmaceutical...

Latest intelligence

Using human insights to push healthcare communications forward
This blog highlights the value of human perspectives, showing how insights can propel healthcare communications forward to ultimately improve lives...
RWE Blog 4: The place of real-world evidence in the market access strategy
The fourth and final blog in our latest series focuses on market access strategy. This follows our evaluation of the role of real-world data (RWD) and real-world evidence (RWE) in...
RWE Blog 3: Is real-world evidence the holy grail
We began our four-blog series by evaluating the role of real-world data (RWD) and real-world-evidence (RWE) in Real-world challenges and real-world data, and understanding the payer's perspective, in Payers use...

Infographics